HIGHLIGHTS
- who: Yaozhong Hu et al. from the Research Institute of Public Health, School of Medicine, Nankai University, Tianjin, China have published the paper: Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting, in the Journal: (JOURNAL) of 19/07/2022
- what: This study provided several Nbs with the potential to be developed as targeting moiety of drug conjugates. Up to date, therapeutic strategies against Trop-2 have been extensively explored to either inhibit Trop-2 mediated tumor invasion or metastasis with solely employed anti-Trop-2 antibodies or facilitate drug delivery to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.